Modulation of atrioventricular nodal function by metabolic and allosteric regulators of endogenous adenosine in guinea pig heart

Circulation

Volumn 94, Issue 10, 1996, Pages 2551-2559

  Dennis, Donn M ^a   Raatikainen, M J Pekka ^a   Martens, Jeffrey R ^a   Belardinelli, Luiz ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

antiarrhythmia agents; arrhythmia; electrophysiology; pharmacology; tachycardia

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE KINASE; ANTIARRHYTHMIC AGENT; DILTIAZEM; DRAFLAZINE; TUBERCIDIN DERIVATIVE;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CONTROLLED STUDY; DRUG DESIGN; DRUG MECHANISM; EPICARDIUM; GUINEA PIG; HEART ATRIUM PACING; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HIS BUNDLE; ISOLATED HEART; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

EID: 0029828718     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.10.2551     Document Type: Article

References (34)

1. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;22:73-97.
2. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine. Circulation. 1991;83:1499-1509.
3. Clemo HF, Belardinelli L. Effect of adenosine on atrioventricular conduction, I: site and characterization of adenosine action in the guinea pig atrioventricular node. Circ Res. 1986;59:427-436.
4. Belardinelli L, Lerman BB. Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias. Br Heart J. 1990;63:3-4.
5. Merideth J, Mendez C, Mueller WJ, Moe GK. Electrical excitability of atrioventricular nodal cells. Circ Res. 1968;23:69-85.
6. Bilette J, Janse MJ, van Capelle FJL, Anderson RH, Touboul P, Durrer D. Cycle-length-dependent properties of AV nodal activation in rabbit hearts. Am J Physiol. 1976;231:1129-1139.
7. Loeb JM, DeTarnowski JM, Whitson CC, Warner MR. Atrioventricular nodal accommodation: rate and time-dependent effects. Am J Physiol. 1987;252:H578-H584.
8. Jenkins JR, Belardinelli L. Atrioventricular nodal accommodation in isolated guinea pig hearts: physiological significance and role of adenosine. Circ Res. 1988;63:97-116.
9. Belardinelli L, Shryock JC. Does adenosine function as a retaliatory metabolite in the heart? News Physiol Sci. 1992;7:52-56.
10. Stark G, Sterz F, Starke U, Bachernegg M, Decrinis M, Tritthart HA. Frequency-dependent effects of adenosine and verapamil on atrio-ventricular conduction of isolated guinea pig hearts. J Cardiovasc Pharmacol. 1993;21:955-959.
11. Nayebpour M, Billette J, Amellal F, Nattel S. Effects of adenosine on rate-dependent atrioventricular nodal function: potential roles in tachycardia termination and physiological regulation. Circulation. 1993;88:2632-2645.
12. Lai W-T, Chee-Siong L, Wu S-N. Rate-dependent properties of adenosine-induced negative dromotropism in humans. Circulation. 1994; 90:1832-1839.
13. Camm AJ, Garratt CJ. Adenosine and supra ventricular tachycardia. N Engl J Med. 1991;325:1621-1629.
14. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinman MM, Govier WC. Adenosine for paroxysmal supra ventricular tachycardia: dose ranging and comparison with verapamil. Ann Intern Med. 1990;113:104-110.
15. Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med. 1995;332:162-173.
16. 1-adenosine selective enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J Pharmacol Exp Ther. 1993;266:611-617.
17. Kollias-Baker C, Ruble J, Dennis D, Bruns RF, Linden J, Belardinelli L. Allosteric enhancer PD81,723 acts by novel mechanism to potentiate cardiac actions of adenosine. Circ Res. 1994;75:961-971.
18. Kollias-Baker C, Xu J, Pelleg A, Belardinelli L. Novel approach for enhancing atrioventricular nodal conduction delay mediated by endogenous adenosine. Circ Res. 1994;75:972-980.
19. Lerman BB, Wesley RC, Belardinelli L. Electrophysiological effects of dipyridamole on atrioventricular nodal conduction and supraventricular tachycardia: role of endogenous adenosine. Circulation. 1989;80:1536-1543.
20. Conti JB, Curtis AB, Utterback D, Belardinelli L. Endogenous adenosine is an antiarrhythmic agent. Circulation. 1994;91:1761-1769.
21. Krebs HA, Henseleit K. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe Seylers Z Physiol Chem. 1932;210:333-336.
22. Langendorff O. Untersuchungen am überlebenden Saugetierherzen. Pflügers Arch ges Physiol. 1895;61:291-332.
23. Jenkins JR, Clemo HF, Belardinelli L. A microcomputer system for on-line study of atrioventricular node accommodation. Pacing Clin Electrophysiol. 1987;10:1301-1308.
24. Tietjan CS, Tribble CG, Gidday JM, Phillips CL, Belardinelli L. Interstitial adenosine in guinea pig hearts: an index obtained by epicardial disk. Am J Physiol. 1990;259:H1471-H1476.
25. Alphin RS, Martens JR, Dennis DM. Frequency-dependent effects of propofol on atrioventricular nodal conduction in guinea pig isolated heart: mechanisms and potential antidysrhythmic properties. Anesthesiology. 1995;83:382-394.
26. Kroll K, Decking UKM, Deikorn K, Schrader J. Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart. Circ Res. 1993;73:846-856.
27. Ely SW, Matherne P, Coleman SD, Berne RM. Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flow. J Mol Cell Cardiol. 1992;24:1321-1332.
28. Wang T, Mentzer RM, Van Wylen DGL. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol. 1992;32:H552-H558.
29. Newby AC. The interaction of inhibitors with adenosine metabolizing enzymes in intact isolated cells. Biochem Pharmacol. 1981;30: 2611-2615.
30. Van Belle H, Janssen PAJ. Comparative pharmacology of nucleoside transport inhibitors. Nucleosides Nucleotides. 1991;10:975-982.
31. Van Belle H. Specific metabolically active antiischemic agents: adenosine and nucleoside transport inhibitors. In: Singh B, Dzan V, Vanhoutte P, Woosley R, eds. Cardiovascular Pharmacology and Therapeutics. New York, NY: Churchill-Livingstone Inc; 1993: 217-245.
32. Bruns RF, Lu GH, Pugley TA. Adenosine receptor subtypes: binding studies. In: Becker B. Gerlach E, eds. Topics and Perspectives of Adenosine Research. Berlin, Germany: Springer-Verlag; 1987:59-73.
33. Belardinelli L, Shryock J, West GA, Clemo HF, DiMarco JP, Berne RM. Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts. Circulation. 1984;70: 1083-1091.
34. 1-adenosine receptors in guinea pig atrioventricular node. Am J Physiol. 1992;262:H661-H671.